The CEO of Pfizer, Albert Bourla, denied on Tuesday that the pharmaceutical company delay until after the US elections the announcement about the effectiveness of its vaccine against COVID-19, contrary to what was affirmed by the president of the country, Donald Trump.

Pfizer and BioNTech to usher in the era of messenger RNA vaccines

“We do not conspire with anyone, of course”said Bourla asked about it during a forum organized by The New York Times, in which the head of the American company has assured that at no time was he pending the elections.

“The elections were always for us an artificial line. It could be very important for the president, but not for us ”, he insisted.

Trump, via Twitter, suggested a possible conspiracy between Pfizer and its partner BioNTech and the Democrats to delay the announcement until after the November 3 election.

“The elections were always for us an artificial line. It could be very important for the president, but not for us “

According to the president, Pfizer “Did not have the courage” to make known before the elections the results of their tests, according to which the vaccine is 90% effective.

Deadlines were delayed

Pfizer and BioNTech, working together on the project, had previously raised the possibility that preliminary results of the study would be available for the end of October, but that schedule was delayed by a stricter protocol agreed with the US Food and Drug Administration (FDA).

A technician from Moderna, one of the pharmaceutical companies working on the development of a vaccine against COVID-19.
Modern pharmaceutical company announces a vaccine more effective than Pfizer’s and easier to keep cold

The two companies continue to accumulate data on the safety and efficacy of the vaccine and hope to produce 50 million dosesthis year and 1.3 billion doses in 2021.

After the announcement of Pfizer and BioNTech, this Monday the biotech Moderna announced that its possible vaccine against COVID-19 is 94% effective and thus becomes the second option to start a mass vaccination campaign against the coronavirus in 2021.